Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosis
Atherosclerosis is featured as chronic low-grade inflammation in the arteries, which leads to the formation of plaques rich in lipids. M2 macrophage-derived extracellular vesicles (M2EV) have significant potential for anti-atherosclerotic therapy. However, their therapeutic effectiveness has been hi...
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
KeAi Communications Co., Ltd.
2024-05-01
|
| Ráidu: | Bioactive Materials |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2452199X24000604 |